Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPCORITAMAB-BYSP Cause Pneumonia? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Pneumonia have been filed in association with EPCORITAMAB-BYSP. This represents 3.0% of all adverse event reports for EPCORITAMAB-BYSP.

29
Reports of Pneumonia with EPCORITAMAB-BYSP
3.0%
of all EPCORITAMAB-BYSP reports
16
Deaths
13
Hospitalizations

How Dangerous Is Pneumonia From EPCORITAMAB-BYSP?

Of the 29 reports, 16 (55.2%) resulted in death, 13 (44.8%) required hospitalization, and 3 (10.3%) were considered life-threatening.

Is Pneumonia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does EPCORITAMAB-BYSP Cause?

Cytokine release syndrome (369) Diffuse large b-cell lymphoma (206) Diffuse large b-cell lymphoma refractory (198) Pyrexia (79) Immune effector cell-associated neurotoxicity syndrome (77) Covid-19 (39) Neutrophil count decreased (35) Hypogammaglobulinaemia (32) Platelet count decreased (32) Cytomegalovirus infection (31)

What Other Drugs Cause Pneumonia?

LENALIDOMIDE (14,807) ADALIMUMAB (11,570) RITUXIMAB (11,068) METHOTREXATE (10,278) PREDNISONE (8,472) ETANERCEPT (8,225) DEXAMETHASONE (6,073) INFLIXIMAB (5,885) POMALIDOMIDE (5,792) TOCILIZUMAB (5,484)

Which EPCORITAMAB-BYSP Alternatives Have Lower Pneumonia Risk?

EPCORITAMAB-BYSP vs EPERISONE EPCORITAMAB-BYSP vs EPHEDRINE EPCORITAMAB-BYSP vs EPINASTINE EPCORITAMAB-BYSP vs EPINEPHRINE EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE

Related Pages

EPCORITAMAB-BYSP Full Profile All Pneumonia Reports All Drugs Causing Pneumonia EPCORITAMAB-BYSP Demographics